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ABSTRACT
Baicalein induces the formation of superoxide and hydroxyl radicals via 12-lipoxygenase (12-LOX) in the B16F10 mouse melanoma
cell line; baicalein also causes a reduction in cellular viability and induces cell apoptosis. In this study, we utilized ROS scavengers to
evaluate the role of ROS in baicalein-induced cell death and used the 12-LOX downstream product, 12-hydroxyeicosatetraenoic acid
(12-HETE), to counterbalance the 12-LOX-inhibitory action of baicalein. ROS scavengers had no effect on cell differentiation, but in the
cellular viability (MTT) assay, ROS scavengers effectively reversed cell viability reduction induced by baicalein. A Western blot analysis
revealed that the ROS scavengers had no effect on the cell apoptosis protein, active caspase-3. From the aspect of 12-LOX, 12-HETE
had no effect on cell differentiation, but it effectively reversed the reduction in cellular viability caused by baicalein in B16F10 cells.
12-HETE also possessed an inhibitory effect on the increase in expression of active caspase-3 caused by baicalein. Combined pretreatment with ROS scavengers and 12-HETE minimized the damage caused by baicalein. The majority of cell death occurring in response
to baicalein-induced ROS formation in B16F10 mouse melanoma was due to cell necrosis. Cell apoptosis due to 12-LOX suppression by
baicalein only accounted for a small portion.
Key words: baicalein, 12-lipoxygenase, reactive oxygen species, B16F10 cells, apoptosis, necrosis

INTRODUCTION
Baicalein (5,6,7-trihydroxyflavone), a bioactive flavonoid extracted from the root of Scutellaria baicalensis or
Scutellaria radix, is frequently used to treat chronic hepatitis in China and Japan. It possesses anti-inflammatory(1,2),
antithrombotic(3) and antioxidant effects(4,5), and produces
cell cycle arrest and suppression of proliferation in cancer
cells(6-8).
Baicalein was confirmed to inhibit the activity of
12-lipoxygenase (12-LOX)(9) and is widely used to decrease
12-hydroxyeicosatetraenoic acid (12-HETE) generation in
cell proliferation studies. Breast, colorectal, and prostate
cancers, were reported to overexpress 12-LOX which was
suggested to be a regulator of cancer cell growth(10-12).
12-LOX levels are associated with the grade and stage of
human prostate tumors(13). The addition of 12-HETE in
the presence of baicalein inhibited the loss of phosphorylated retinoblastoma (pRB) protein in PC3 cells, whereas
12-HETE alone induced pRB expression(14).
* Author for correspondence. Tel: +886-2-27390450;
Fax: +886-2-27390450; E-mail: fird@tmu.edu.tw
#
These authors Contributed equally to this study.

Reactive oxygen species (ROS) can cause membrane
damage and lead to cell death via apoptosis or necrosis(15).
Although some natural herbal compounds have been
reported to destroy tumor cells by the generation of ROS, the
mechanisms concerning how ROS is induced have not been
clarified(16).
Baicalein induces the apoptosis of Jurkat cells(17), HL60
(18)
cells , and mouse-rat hybrid retina ganglion cells(19), all of
which are accompanied by intracellular ROS generation. In
normal cells, our previous study demonstrated that baicalein
induces hydroxyl radical formation in human platelets which
contain a 12-LOX isoform (p12-LOX), but baicalein does not
induce ROS in rat vascular smooth muscle cells and human
umbilical vein endothelial cells(20). In B16F10 cells, we also
detected hydroxyl radicals and superoxide anion radicals
generated by baicalein via 12-LOX, and found that baicalein
caused a reduction in cellular viability. In addition, decreases
in 12-LOX protein expression and free radical generation
occurred in a 12-LOX small interfering RNA knockdown
protein group compared with the baicalein control(21). Those
results suggested that ROS formation catalyzed by 12-LOX
is one possible mechanism of baicalein-induced cell death,
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but the precise mechanism, apoptosis or necrosis, is still
ambiguous.
Baicalein was recently shown to enhance TRAILinduced apoptosis by the induction of a CCAAT/enhancerbinding protein homologous protein (CHOP). In contrast,
baicalein increases TRAIL-R2 expression through a ROSmediated mechanism independent of CHOP in human prostate cancer PC-3 cells(22). However, baicalein barely induces
apoptosis in normal cells. The mechanism of distinguishing
tumor from normal cells by Baicalein remains unknown.
In the present study, we demonstrated that B16F10 mouse
melanoma cell death caused by baicalein was mainly due to
ROS generation through 12-LOX, which suggests that the
majority of cell death was due to cell necrosis. Cell apoptosis
caused by 12-LOX suppression of baicalein accounted for
only a small portion.

Materials and Methods
I. Materials
Arachidonic acid (AA), aprotinin, 4-hydroxy-3methoxyacetophenone (acetovanillone), catalase (CAT),
dimethyl sulfoxide (DMSO), dithiothreitol (DTT),
5,5-dimethyl-1-pyrroline N-oxide (DMPO), N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES), mannitol,
tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), phenylmethylsulfonyl fluoride
(PMSF) and quinacrine were purchased from Sigma Chemical (St. Louis, MO, USA). 1-Hydroxy-3-methoxycarbonyl2,2,5,5-tetramethylpyrrolidine HCl (CMH) was purchased
from Alexis (San Diego, CA, USA). Baicalein was purchased
from Aldrich Chemical (Milwaukee, WI, USA). Sodium
dodecylsulfate (SDS), Triton X-100 and Tris-base were
obtained from Amersham Life Sciences (Arlington Heights,
IL, USA). Polyoxyethylenesorbitan monolaurate (Tween 20),
N,N,N,N,-tetramethylethylethylenediamine (TEMED) and
glycerol were purchased from Pharmacia Biotech (Piscataway, NJ, USA). Amphotericin B (fungizone), Dulbecco’s
modified Eagle medium (DMEM), porcine elastase, fetal
calf serum (FCS), L-glutamine, Hank’s balanced salt solution (HBSS), penicillin/streptomycin, sodium pyruvate,
trypan blue stain and trypsin-EDTA were purchased from
Gibco BRL (Grand Island, NY, USA). The 12-lipoxygenase
primary antibody and cleaved caspase-3 rabbit (ASP175)
antibody were purchased from Sigma Chemical, Abcam
(Cambridge, UK) and Cell Signaling Technology (Beverly,
MA, USA), respectively. Horseradish peroxidase (HRP)conjugated sheep anti-mouse and anti-rabbit antibodies were
obtained from Amersham (Bucks, UK), and mouse and
rabbit control immunoglobulin G (IgG) was purchased from
Organon Teknika-Cappel (Malvern, PA, USA).
II. Tumor Cell Lines and Cell Culture
B16F10 murine melanoma cells were obtained from the

National Institute of Preventive Medicine, Department of
Health, Executive Yuan (Taipei, Taiwan) and were cultured
at 37°C under a humid atmosphere and 5% CO2, in DMEM
medium with 10 mM of HEPES, 24 mM of sodium bicarbonate, 40 mg/L of gentamycin (pH 7.2) and 10% FCS.
III. Morphological Study
After the cells had been incubated with baicalein (10, 25
and 50 μM) for 12 h, the cell morphology was observed and
images were captured under a light microscope connected to
a digital camera (Nikon TS100, Japan).
IV. Proliferation Assay
Cell viability was assessed using a standard MTT
assay. B16F10 cells in the exponential growth phase were
suspended in DMEM containing 10% FCS and cultured in
flat-bottomed, 96-well plates (2 × 104 cells/well) for 24 h at
37°C, followed by the addition of baicalein. The final concentrations of the drug were 10, 25 and 50 μM, and plain DMEM
was used as the negative control. The plates were incubated
in a humidified incubator of 5% CO2 at 37°C for 6, 12, 18 and
24 h. The supernatants were discarded after centrifugation.
MTT (0.5 mg/mL) at 100 μL/well was added to the plates and
incubation continued for 3 h. The supernatant was then carefully removed and 300 μL of DMSO was added to dissolve
the formazan crystals. The optical density at 540 nm was
read using an enzyme-linked immunosorbent assay (ELISA)
reader. The percentage of cell viability was calculated as the
absorbance of treated cells/control cells × 100%.
V. Flow Cytometric Analysis
B16F10 cells were seeded onto six-well plates at a
density of 5 × 104 cells per well and incubated for 24 h before
the experiment. The cells were washed with PBS, treated
with media containing baicalein in DMSO and incubated
for 24 h. Supernatants and collected cells were centrifuged,
and cell pellets were suspended in 1× calcium buffer at a
rate 105 cells/100 μL. The cells were stained with annexin
(BD 556420) and propidium iodide (PI; Sigma P4864) in a
dark room for 15 min. The DNA content was determined
on a flow cytometer (Becton Dickinson, FACScan Syst.,
San Jose, CA, USA). Percentages of apoptotic, necrotic,
and decompensated cells were calculated among all viable
cells (100%). All experiments were repeated three times to
ensure reproducibility.
VI. Western Blotting
To determine the expression of caspase-3, B16F10 cells
were cultured on 24-well plates and treated with baicalein
or an isovolumetric solvent control for 12 h. At the indicated
times, the cells were washed with ice-cold PBS buffer (pH
7.3). Proteins were extracted with lysis buffer for 30 min.
Lysates were centrifuged and the supernatant (60 - 80 μg
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protein) was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and electrophoretically transferred onto
polyvinylidene difluoride (PVDF) membranes (0.45 µm;
Hybond-P; Amersham). Samples were mixed with sample
buffer, boiled for 10 min, separated by 0.1% SDS, subjected
to 10% polyacrylamide gel electrophoresis under denaturing
conditions and electroblotted onto Immobilon-P membranes
(Millipore). The membranes were blocked with TBS (5%
non-fat dry milk, 0.1% Tween 20 in 50 mM of Tris-HCl
buffer and 150 mM of NaCl; pH 7.5) overnight at 4°C. The
membranes were incubated with an anti-12-lipoxygenase,
anti-α-tubulin, anti-lamin A/C, anti-caspase-3 or anti-β-actin
antibody (Sigma) for 3 h at room temperature. After four
washes in TBS/0.1% Tween 20, the membranes were probed
with a secondary goat anti-rat (Santa Cruz Technology, Santa
Cruz, CA, USA) or goat anti-mouse (KPL) antibody, each
conjugated to HRP. After washing four times with TBS
and 0.1% Tween 20, the band with peroxidase activity was
detected using film exposure with enhanced chemiluminescence detection reagents (ECL+ system, Amersham). Densitometric analysis of specific bands was performed using
a Photo-Print Digital Imaging System (IP-008-SD) with
analytic software (Bio-1Dlight, V 2000).
VII. Statistical Analysis
Experimental results are expressed as the mean ± SEM
and are accompanied by the number (n) of observations. Data
were assessed using an analysis of variance (ANOVA). If this
analysis indicated significant differences among the group
means, then each group was compared using the NewmanKeuls method. A p value of less than 0.05 was considered
statistically significant.

Results
I. Effect of ROS Scavengers on Baicalein-Induced
Inhibition of Proliferation of B16F10 Melanoma Cells
We compared the effects of the spin-trappers, CMH and
DMPO, with the extracellular ROS scavengers, mannitol
and catalase, on baicalein-induced proliferation inhibition
in B16F10 melanoma cells in this study. We first evaluated
morphological changes induced by baicalein and the effects
of ROS scavengers on baicalein-induced morphological
changes. B16F10 melanoma cells were treated with 50 μM
of baicalein for 24 h. ROS scavengers were administered 1 h
before baicalein. As shown in Figure 1, B16F10 cells became
much more spindly in shape after 24 h, and some of the cells
seemed to have broken down (Figure 1B). Both pretreatment
with 25 mM of mannitol (Figure 1C) and 300 unit/mL of catalase (Figure 1D) both increased the number of cells without
obvious changes to the cell morphology. Similar results were
observed in groups pretreated with spin-trappers, CMH
(Figure 1E) and DMPO (Figure 1F).

II. Effect of Adding 12-HETE Back on Baicalein-Induced
Inhibition of Proliferation of B16F10 Melanoma Cells
We evaluated the effects of 12-HETE on baicaleininduced morphological changes. B16F10 melanoma cells
were treated with 50 μM of baicalein for 24 h. 12-HETE was
administered 1 h before baicalein. As shown in Figure 1,
both pretreatments with 500 nM (Figure 1G) and 1000 nM
of 12-HETE (Figure 1H) showed no obvious changes in the
cell morphology.
III. Effects of ROS Scavengers and 12-HETE on BaicaleinInduced Inhibition of Proliferation of B16F10 Melanoma
Cells
To elucidate the mechanisms of inhibition of B16F10 cell
growth by baicalein, we investigated whether ROS scavengers and 12-HETE could reverse the cell shape change effects
of baicalein. The scavengers and 12-HETE were added 1 h
before the addition of baicalein (50 μM for 24 h). The shape
changes obviously decreased (Figure 2) compared to ROS
scavenger-treated or 12-HETE-treated groups (Figure 1).
The effects of ROS scavengers on the proliferation of
B16F10 melanoma cells were determined by a MTT colorimetric survival assay (Figure 3A). All values were normalized to percentage of the control and represented the average
of three independent incubations. Proliferation of groups
of melanoma cells treated with 1 mM of CMH, 10 mM of
DMPO, 25 mM of mannitol and 300 unit/mL of catalase were
higher than the baicalein-treated (50 μM for 24 h) group, and
results were 49.8 ± 7.8%, 72.8 ± 6.8%, 71.3 ± 3.9%, 57.8 ±
4.8% and 80.1 ± 3.3%, respectively. The effects of 12-HETE
on the proliferation of B16F10 melanoma cells were shown in
Figure 3B. Proliferation levels in the 500 nM and 1000 nM
12-HETE-treated groups of melanoma cells were higher than
that of the baicalein-treated (50 μM for 24 h) group, but only
the effect of 1000 nM of 12-HETE was significant, and results
were 55.1 ± 4.5%, 62.2 ± 3.8% and 75.3 ± 2.8%, respectively.
The combined effects of ROS scavengers and 12-HETE on
the proliferation of B16F10 melanoma cells were shown in
Figure 3C. Proliferation of groups of melanoma cells treated
with 1000 nM of 12-HETE and 1 mM of CMH, 1000 nM of
12-HETE and 10 mM of DMPO, 1000 nM of 12-HETE and
25 mM of mannitol, and 1000 nM of 12-HETE and 300 units/
mL of catalase were significantly higher than the baicaleintreated (50 μM for 24 h) group (p < 0.001), and results were
48.6 ± 3.8%, 91.0 ± 2.6%, 88.9 ± 4.6%, 85.9 ± 2.1% and 92.2
± 5.7%, respectively. This indicates that 12-HETE and ROS
generation are involved in baicalein-induced cell death. In
addition, proliferation of groups of melanoma cells treated
with test compounds only showed no significant difference
from the control group (Figure 3D).
IV. Effects of ROS Scavengers on Cleaved Caspase-3 Protein
Expression Induced by Baicalein in B16F10 Melanoma Cells
Caspase-3 plays an important role as an executioner
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Figure 1. Effects of ROS scavengers and 12-HETE, given separately, on baicalein-induced morphological changes in B16F10 melanoma cells.
B16F10 cells were treated with 50 μM of baicalein for 24 h. ROS scavengers were administered for 1 h before baicalein. The cells were washed
with PBS three times before viewing under microscopy. (A) Resting, (B) 50 μM of baicalein, (C) 50 μM of baicalein + 25 mM of mannitol, (D)
50 μM of baicalein + 300 units/mL of catalase, (E) 50 μM of baicalein + 1 mM of CMH, (F) 50 μM of baicalein + 10 mM of DMPO, (G) 50 μM
of baicalein + 500 nM of 12-HETE, (H) 50 μM of baicalein + 1000 nM of 12-HETE (magnification: ×100).

in the apoptotic process. During apoptosis, the Mr-32,000
procaspase-3 is cleaved into Mr-17,000 and Mr-11,000 forms
of active caspase-3(23). Our results showed that baicalein
induced marked caspase-3 activation in B16F10 melanoma
cells after 24 h of treatment, while pretreatment with 25 mM
of mannitol, 300 unit/mL of catalase, 1 mM of CMH and 10
mM of DMPO showed no significant effect (Figure 4). This
result indicated that ROS are involved in baicalein-induced
cell death but not cell apoptosis.
V. Effects of 12-HETE and Scavengers on Cleaved Caspase-3
Protein Expression Induced by Baicalein in B16F10
Melanoma Cells
As shown in Figure 5, we observed that baicalein
induced marked caspase-3 activation in B16F10 melanoma
cells after 24 h of treatment, and pretreatment with 500 nM
and 1000 nM of 12-HETE decreased this activation, but

only the effect of 1000 nM of 12-HETE was significant.
This reveals that 12-HETE is involved in baicalein-induced
B16F10 cell apoptosis.
VI. Induction of Apoptosis and Necrosis by Baicalein in
B16F10 Cells
A flow cytometric assay was used to quantify apoptotic and necrotic cells treated with 50 μM of baicalein.
Treated and untreated B16F10 cells were stained with
annexin V-FITC and PI. Annexin V-FITC staining is used
in conjunction with the dye PI to distinguish between cells
that are early in apoptosis from those late in apoptosis.
Figure 6 shows the cytotoxic response in B16F10 cells
treated with baicalein. The apoptotic index is the sum of the
percentage of cells that were positive for annexin-V-FITC
alone (pre-apoptotic) and cells positive for both annexin-VFITC and PI (late-apoptotic) within a population of cells.
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Figure 2. Effects of ROS scavengers plus 12-HETE on baicalein-induced morphological changes in B16F10 melanoma cells. B16F10 cells were
treated with 50 μM of baicalein for 24 h. ROS scavengers and 12-HETE were added 1 h before treatment with baicalein. The cells were washed
with PBS three times before examination by microscopy. (A) Resting, (B) 50 μM of baicalein, (C) 50 μM of baicalein + 1000 nM of 12-HETE +
1 mM of CMH, (D) 50 μM of baicalein + 1000 nM of 12-HETE + 10 mM of DMPO, (E) 50 μM of baicalein + 1000 nM of 12-HETE + 25 mM of
mannitol, (F) 50 μM of baicalein + 1000 nM of 12-HETE + 300 unit/mL of catalase (magnification: ×100).
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Figure 3. Effects of ROS scavengers plus 12-HETE on baicalein-induced inhibition of proliferation of B16F10 melanoma cells. B16F10 melanoma cells (5 × 104 cells/mL ) were dispensed on 96-well plates until 80 - 90% confluent. (A) Cells were treated with 1 mM of CMH, 10 mM of
DMPO, 25 mM of mannitol or 300 units/mL of catalase for 1 h; (B) cells were treated with 500 nM or 1000 nM of 12-HETE for 1 h; (C) cells
were treated with 1000 nM of 12-HETE and ROS scavengers, and 10 mM of DMPO, 1 mM of CMH, 25 mM of mannitol or 300 units/mL of
catalase for 1 h, before treatment with 50 μM baicalein for 24 h; (D) cells were treated with the indicated concentration of test compounds only.
The percentage of viable cells is presented as the mean ± SEM of three independent experiments. ***p < 0.001; **p < 0.01; *p < 0.05, compared
to baicalein treatment only.
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Figure 4. Effects of ROS scavengers and baicalein on cleaved
caspase-3 protein in B16F10 melanoma cells. The cells were treated
with the indicated concentration of 1 mM of CMH, 10 mM of DMPO,
25 mM of mannitol or 300 unit/mL of catalase for 1 h before treatment with 50 μM of baicalein for 24 h. The bar graph depicts the
ratios of quantitative results obtained by scanning the anti-cleaved
caspase-3 and anti-α-tubulin reactive bands and quantifying the
optical density using Bio-1D version 99 image software. Data are
presented as the mean ± SEM (n = 3).
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Figure 5. Effects of 12-HETE on baicalein-induced cleaved
caspase-3 protein expression in B16F10 melanoma cells. The cells
were treated with the indicated concentration of 500 nM or 1000 nM
of 12-HETE for 1 h before treatment with 50 μM of baicalein for 24 h.
The bar graph depicts the ratios of quantitative results obtained by
scanning the anti-cleaved caspase-3 and anti-α-tubulin reactive bands
and quantifying the optical density using Bio-1D version 99 image
software. Data are presented as the mean ± SEM (n = 3). ***p < 0.001,
compared to baicalein treatment only.
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Figure 6. Flow cytometric analysis of apoptosis in B16F10 melanoma cells following treatment with baicalein. (A) Control cells; (B) cells
treated with 50 µM of baicalein.

337
Journal of Food and Drug Analysis, Vol. 19, No. 3, 2011

The necrosis index is the sum of the percentage of cells that
were positive for PI within a population of cells. Untreated
cells were primarily annexin V-FITC and PI negative
(lower left quadrant, panel A), indicating that the cells were
viable. In comparison with untreated B16F10 cells which
showed 4.25% background cell death (upper left quadrant
and upper right quadrant, panel A), cells treated with 50
μM of baicalein showed 41.24% cell death, including 8.98%
by apoptosis (upper right quadrant, panel B) and 32.26% by
necrosis (upper left quadrant, panel B). This indicated that
the majority of cell death induced by baicalein is through
cell necrosis.

Discussion
Based on several studies, baicalein can induce apoptosis in various cancer cells and the mechanisms of action
are associated with caspase activation and mitochondrial
dysfunction(14,24-26). However, there is no available information to address the roles of ROS in the induction of cell death
caused by baicalein. Li et al. suggested that ROS and cellular
Ca2+ modulate baicalein-induced apoptosis via a Ca2+dependent mitochondrial death pathway in mouse-rat hybrid
retina ganglion cells and demonstrated release of Cyt c from
mitochondria into the cytosol and activation of caspase3(19). In our previous study, we demonstrated that baicalein
induced the formation of ROS via 12-LOX in the B16F10
mouse melanoma cell line(21). In the present investigation,
we utilized extracellular ROS scavengers, mannitol and catalase, and intracellular ROS scavengers, DMPO and CMH, to
evaluate the role of ROS in baicalein-induced cell death. Our
data demonstrated that ROS scavengers decreased baicaleininduced cell death but did not affect the level of activated
caspase-3, providing further evidence that ROS are not associated with baicalein-induced apoptosis in B16F10 cells. One
interpretation of this observation is that ROS-induced cell
death may be due to cell necrosis.
AA release from cell membranes is necessary for
cancer cell proliferation. Moreover, LOX catalyzes AA
into hydroperoxyeicosatetraenoic acid (HPETE) and finally
to hydroxyeicosatetraenoic acid (HETE) or to leukotrienes. Many cancer cell lines express 12-LOX and produce
12-HETE(27,28), which can stimulate cancer growth via activation of the p44/42 mitogen-activated protein kinase and
PI3/Akt kinase pathways(29). Furthermore, 12-HETE can
facilitate the invasion and metastasis of cancer cells(30,31).
The addition of exogenous 12-HETE increased the incorporation of thymidine into DNA in a dose-dependent
manner in A431 human epidermoid carcinoma cells(32,33).
Prostate(14) and gastric cancer cells(26) were also reported
to increase proliferation in response to 12-HETE. In this
study, we found that 12-HETE had no effect on cell growth
differentiation, but it effectively reversed the reduction in
cellular viability caused by baicalein in B16F10 cells. This
result was similar to that with ROS scavengers. In addition,
12-HETE also possessed an inhibitory effect on the

increase in expression of active caspase-3 caused by baicalein. Finally, we pretreated ROS scavengers and 12-HETE
at the same time and the results showed that the combined
treatment minimized the damage caused by baicalein.
Our results conclusively demonstrate that B16F10
mouse melanoma cell death caused by baicalein is related to
both 12-LOX suppression and ROS generation, but apoptosis
only occurs because of 12-LOX suppression by baicalein.
Moreover, we used cytometric analysis to examine cell death
caused by baicalein and found that cell necrosis was the major
mode of cell death and that apoptosis plays only a minimal
role. Taking together, we concluded that the majority of cell
death occurring in response to baicalein-induced ROS formation in B16F10 mouse melanoma cells was due to necrosis.
Cell apoptosis caused by 12-LOX suppression of baicalein
only accounted for a small portion.
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